US$ 25.67
retatrutide and ghk cu GHK-Cu Peptides (retatrutide GHK-CU) and more
Description
While not statistically significant, GLP-1 RAs also exhibited a trend towards fewer myocardial infarctions (HR 0.83) and lower mortality rates (HR 0.83) than SGLT2 inhibitors

I'm more active

I started GLP-1 drugs in January 2024 at age 70, and two years later, I've lost 90 pounds and more

Now that the FDA has shut the door on mass compounded semaglutide, this is the most affordable and safest way to get started on a real FDA approved GLP-1

The seller provides no medical advice, dosing guidance, or therapeutic claims

Supplied in lyophilised peptide format
